Research and Markets has announced the addition of the "Rosacea Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Rosacea Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Rosacea market. It covers emerging therapies for Rosacea in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Rosacea pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Rosacea pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Rosacea pipeline products by the company.

Short-term Launch Highlights:

Find out which Rosacea pipeline products will be launched in the US and Ex-US till 2020.

Summary:

  • Rosacea phase 3 clinical trial pipeline products
  • Rosacea phase 2 clinical trial pipeline products
  • Rosacea phase 1 clinical trial pipeline products
  • Rosacea preclinical research pipeline products
  • Rosacea discovery stage pipeline products
  • Rosacea pipeline products short-term launch highlights

Key Topics Covered:

1. Rosacea Pipeline by Stages

2. Rosacea Pipeline by Drug Class

3. Rosacea Pipeline by Company

4. Rosacea Phase 3 Clinical Trial Insights

5. Rosacea Phase 2 Clinical Trial Insights

6. Rosacea Phase 1 Clinical Trial Insights

7. Rosacea Preclinical Research Insights

8. Rosacea Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/crblmb/rosacea_pipeline